769 |
From docs post: Generex Biotechnology Corp |
tc2000chartreader |
12/21/2018 4:59:06 PM |
767 |
Wheres the 300k figure from? Pre div |
rjs9787 |
12/21/2018 4:15:21 PM |
766 |
This market stinks, headed for |
OrlandoJohn |
12/21/2018 3:58:27 PM |
765 |
Wonder if this is a double bottom? Didn't we hit |
tc2000chartreader |
12/21/2018 2:56:05 PM |
764 |
.66 low today. wow. Where is the |
OrlandoJohn |
12/21/2018 12:19:31 PM |
763 |
Selling is nefarious ;) Maybe we'll see some more |
docj |
12/21/2018 11:59:48 AM |
762 |
I think they are sellers. Im not suggesting (1) |
rjs9787 |
12/21/2018 11:46:17 AM |
761 |
In case anyone is interested this is the company |
docj |
12/21/2018 11:30:16 AM |
760 |
They were the ones who held up the dividend date |
docj |
12/21/2018 11:21:42 AM |
758 |
The group that concerns me if Alpha |
rjs9787 |
12/21/2018 10:34:17 AM |
757 |
Darn MM's asleep at the wheel today. I don't see |
docj |
12/21/2018 10:09:38 AM |
756 |
Looks like we have some eager sellers again this |
docj |
12/21/2018 9:22:00 AM |
755 |
In the last AE37 study, 89% were disease free at (2) |
Creekrat |
12/21/2018 8:31:12 AM |
754 |
Thanks rjs -Good info on the trial - now we know |
Creekrat |
12/21/2018 7:15:24 AM |
753 |
Welcome aboard, gmin! I think that CEO Joe and AE (3) |
rjs9787 |
12/20/2018 11:49:40 PM |
752 |
Great info rjs, thanks !! |
GMIN |
12/20/2018 11:08:34 PM |
751 |
Ae37/Keytruda is a new trial. The one you note |
rjs9787 |
12/20/2018 10:18:40 PM |
750 |
rjs , agree but look at the estimated completion |
GMIN |
12/20/2018 9:57:50 PM |
749 |
This explains the study a bit and is relatively |
docj |
12/20/2018 9:54:38 PM |
748 |
I think thats the previous study of Keytruda |
rjs9787 |
12/20/2018 9:32:53 PM |
747 |
Keep in mind that filing wasnt the quarterly |
rjs9787 |
12/20/2018 9:28:17 PM |
746 |
Creek, maybe this link will provide some answers. |
GMIN |
12/20/2018 4:41:53 PM |
745 |
Last minute trade to $1/share. What was that all |
OrlandoJohn |
12/20/2018 4:01:32 PM |
743 |
Now that you mention it - I have been looking for (1) |
Creekrat |
12/20/2018 1:53:52 PM |
742 |
PURA/GNBT PURA - Puration 2018 Sales Exceed $1 |
docj |
12/20/2018 12:50:54 PM |
741 |
No PR on the filings about Veneto |
OrlandoJohn |
12/20/2018 12:35:28 PM |
739 |
Preparation for the study is ongoing and they |
docj |
12/20/2018 11:31:17 AM |
738 |
Great board!! Any experts on clinical trial |
GMIN |
12/20/2018 11:17:18 AM |
737 |
Generex Biotechnology Partner Olaregen |
docj |
12/20/2018 11:01:03 AM |
736 |
RE: KALY/GNBT Kali-Extracts and Nouveau Announce |
docj |
12/20/2018 10:28:49 AM |
735 |
Glad we have Joe to explain these things. Most (1) |
Creekrat |
12/20/2018 8:35:17 AM |
734 |
Gotcha, their expenses were high because they |
tc2000chartreader |
12/20/2018 12:00:02 AM |
733 |
Private companies do not operate like public (1) |
MMPJOE |
12/19/2018 11:49:25 PM |
732 |
Excellent revenues Joe. Quick question...with |
tc2000chartreader |
12/19/2018 11:34:13 PM |
731 |
Very Impressive! If not more impressive is the |
BusyBee |
12/19/2018 10:51:29 PM |
730 |
Thanks Joe. I just looked at that previous 8k (1) |
rjs9787 |
12/19/2018 10:19:07 PM |
729 |
Thanks for the info. I will go back and read the (1) |
docj |
12/19/2018 9:53:48 PM |
728 |
If that was me Orlando it would be for a lot more |
tc2000chartreader |
12/19/2018 9:49:16 PM |
727 |
I would think it's pretty clear, we own none of |
MMPJOE |
12/19/2018 9:36:18 PM |
726 |
That is great to hear. I should have figured you |
docj |
12/19/2018 9:26:14 PM |
725 |
The complete assets we acquired is in the asset |
MMPJOE |
12/19/2018 9:22:34 PM |
724 |
We didn't buy any of the tainted assets or the (1) |
MMPJOE |
12/19/2018 9:20:44 PM |
723 |
Joe personally guaranteeing loans stands out to |
rjs9787 |
12/19/2018 8:52:58 PM |
722 |
Figures are nice but the news about the |
docj |
12/19/2018 8:36:26 PM |
721 |
10. COMMITMENTS AND CONTINGENCIES On May 2, 2017, |
rjs9787 |
12/19/2018 8:10:32 PM |
720 |
Sec filing showing Veneto revenues for 12 months (1) |
rjs9787 |
12/19/2018 7:53:48 PM |